Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Methyltransferase Like 3 (METTL3) (C-Term) Peptide

METTL3 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN980006

Aperçu rapide pour Methyltransferase Like 3 (METTL3) (C-Term) Peptide (ABIN980006)

Antigène

METTL3 (Methyltransferase Like 3 (METTL3))

Origine

Humain

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    C-Term

    Séquence

    KIELFGRPHN VQPNWITLGN QLDGIHLLDP DVVARFKQRY PDGIISKPKN

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-METTL3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Indications d'application

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Conseil sur la manipulation

    Avoid repeated freeze-thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    METTL3 (Methyltransferase Like 3 (METTL3))

    Sujet

    This gene encodes the 70 kDa subunit of MT-A which is part of N6-adenosine-methyltransferase. This enzyme is involved in the posttranscriptional methylation of internal adenosine residues in eukaryotic mRNAs, forming N6-methyladenosine.

    Alias Symbols: IME4, M6A, MGC4336, MT-A70, Spo8

    Protein Size: 580

    Poids moléculaire

    64 kDa

    ID gène

    56339

    NCBI Accession

    NM_019852, NP_062826

    UniProt

    Q86U44
Vous êtes ici:
Chat with us!